Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Save
422301 50 tests ¥22,220
422302 200 tests ¥50,380
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  2. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  3. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  4. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  5. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  6. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  7. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  8. Mair F, et al. 2022. Nature. 605:728. PubMed
  9. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  10. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  11. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  12. Campisi L, et al. 2022. Nature. 606:945. PubMed
  13. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  14. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  15. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  16. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  17. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  18. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  19. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  20. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  21. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  22. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  23. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  24. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  25. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  26. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  27. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  28. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  29. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  30. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  31. Sun W, et al. 2023. Nature. 614:309. PubMed
  32. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  33. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  34. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  35. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  36. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  37. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  38. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  39. Wang CQ, et al. 2023. Cells. 12: . PubMed
  40. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  41. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  42. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  43. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  44. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  45. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  46. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  47. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  48. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  49. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  50. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  51. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  52. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  53. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  54. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  55. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  56. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  57. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  58. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  59. Li S, et al. 2022. Nature. 610:373. PubMed
  60. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  61. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  62. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  63. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  64. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  65. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  66. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  67. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  68. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  69. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  70. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  71. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  72. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  73. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  74. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  75. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  76. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  77. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  78. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  79. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  80. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  81. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  82. Gao F, et al. 2023. Immunity. 56:864. PubMed
  83. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  84. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  85. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  86. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  87. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  88. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  89. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  90. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  91. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  92. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  93. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  94. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  95. Solier S, et al. 2023. Nature. 617:386. PubMed
  96. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  97. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  98. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  99. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  100. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  101. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  102. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  103. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  104. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  105. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  106. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  107. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  108. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  109. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  110. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  111. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  112. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  113. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  114. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  115. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  116. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  117. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  118. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  119. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  120. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  121. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  122. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  123. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  124. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  125. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  126. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  127. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  128. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  129. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  130. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  131. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  132. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  133. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  134. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  135. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  136. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  137. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  138. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  139. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  140. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  141. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  142. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  143. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  144. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  145. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  146. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  147. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  148. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  149. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  150. Jairaman A, et al. 2022. Elife. 11:. PubMed
  151. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  152. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  153. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  154. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  155. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  156. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  157. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  158. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  159. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  160. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  161. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  162. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  163. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  164. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  165. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  166. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  167. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  168. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  169. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  170. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  171. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  172. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  173. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  174. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  175. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  176. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  177. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  178. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  179. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  180. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  181. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  182. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  183. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  184. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  185. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  186. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  187. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  188. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  189. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  190. Ogbe A, et al. 2022. JCI Insight. . PubMed
  191. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  192. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  193. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  194. Woodruff MC, et al. 2022. Nature. :. PubMed
  195. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  196. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  197. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  198. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  199. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  200. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  201. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  202. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  203. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  204. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  205. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  206. Kumar V, et al. 2022. Cells. 11:. PubMed
  207. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  208. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  209. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  210. Vijayakumar B, et al. 2022. Immunity. . PubMed
  211. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  212. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  213. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  214. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  215. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  216. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  217. Dogra P, et al. 2020. Cell. 749:180. PubMed
  218. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  219. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  220. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  221. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  222. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  223. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  224. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  225. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  226. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  227. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  228. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  229. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  230. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  231. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  232. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  233. Kreutmair S, et al. 2021. Immunity. . PubMed
  234. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  235. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  236. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  237. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  238. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  239. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  240. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  241. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  242. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  243. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  244. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  245. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  246. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  247. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  248. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  249. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  250. Romine KA, et al. 2021. Cancer Discov. . PubMed
  251. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  252. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  253. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  254. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  255. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  256. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  257. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  258. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  259. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  260. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  261. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  262. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  263. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  264. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  265. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  266. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  267. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  268. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  269. Thijssen R, et al. 2022. Blood. :. PubMed
  270. Good Z, et al. 2022. Nat Med. :. PubMed
  271. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  272. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  273. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  274. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  275. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  276. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  277. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  278. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  279. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  280. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  281. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  282. Shi J, et al. 2014. Blood. 123:4015. PubMed
  283. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  284. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  285. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  286. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  287. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  288. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  289. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  290. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  291. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  292. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  293. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  294. Woodruff M, et al. 2020. medRxiv. . PubMed
  295. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  296. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  297. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  298. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  299. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  300. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  301. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  302. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  303. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  304. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  305. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  306. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  307. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  308. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  309. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  310. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  311. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  312. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  313. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  314. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  315. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  316. Burns JC, et al. 2020. eLife. 9:00. PubMed
  317. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  318. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  319. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  320. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  321. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  322. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  323. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  324. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  325. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  326. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  327. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  328. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  329. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  330. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  331. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  332. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  333. Wang J, et al. 2022. iScience. 25:103971. PubMed
  334. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  335. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  336. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  337. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  338. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  339. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  340. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  341. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  342. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  343. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  344. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  345. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  346. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  347. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  348. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  349. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  350. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  351. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  352. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  353. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  354. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  355. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  356. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  357. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  358. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  359. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  360. Feng W, et al. 2020. J Vis Exp. . PubMed
  361. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  362. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  363. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  364. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  365. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  366. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  367. Song M, et al. 2018. Nature. 562:423. PubMed
  368. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  369. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  370. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  371. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  372. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  373. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  374. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  375. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  376. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  377. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  378. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  379. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  380. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  381. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  382. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  383. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  384. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  385. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  386. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  387. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  388. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  389. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  390. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  391. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  392. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  393. Georg P, et al. 2022. Cell. 185:493. PubMed
  394. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  395. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  396. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  397. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  398. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  399. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  400. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  401. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  402. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  403. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  404. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  405. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  406. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  407. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  408. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  409. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  410. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  411. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  412. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  413. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  414. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  415. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  416. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  417. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  418. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  419. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  420. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  421. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  422. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  423. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  424. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  425. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  426. Lederer K, et al. 2022. Cell. . PubMed
  427. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  428. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  429. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  430. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  431. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  432. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  433. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  434. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  435. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  436. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  437. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  438. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  439. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  440. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  441. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  442. Adamo S, et al. 2022. Nature. 602:148. PubMed
  443. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  444. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  445. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  446. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  447. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  448. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  449. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  450. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  451. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  452. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  453. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  454. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  455. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  456. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  457. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  458. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  459. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  460. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  461. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  462. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  463. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  464. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  465. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  466. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  467. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  468. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  469. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  470. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  471. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  472. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  473. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  474. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  475. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  476. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  477. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  478. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  479. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  480. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  481. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  482. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  483. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  484. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  485. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  486. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  487. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  488. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  489. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  490. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  491. Chen C, et al. 2022. iScience. 25:103645. PubMed
  492. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  493. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  494. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  495. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  496. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  497. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  498. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  499. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  500. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  501. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  502. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  503. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  504. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  505. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  506. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  507. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  508. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  509. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  510. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  511. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  512. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  513. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  514. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  515. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  516. Wang EY, et al. 2021. Nature. 595:283. PubMed
  517. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  518. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  519. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  520. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  521. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  522. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  523. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  524. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  525. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  526. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  527. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  528. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  529. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account